Brandon Mapes

Title: The Innovative Contributions of Brandon Mapes

Introduction

Brandon Mapes is a notable inventor based in Chicago, IL (US). He has made significant strides in the field of cancer research through his innovative patent. His work focuses on enhancing the efficacy of cellular therapies in cancer treatment.

Latest Patents

Brandon Mapes holds a patent titled "Platform for co-culture imaging to characterize in vitro efficacy of heterotypic effector cellular therapies in cancer." This patent describes a method for characterizing cancer organoid response to immune cell-based therapy. The process involves providing a panel of different combinations of cancer organoid cells and immune cells to culturing wells. These combinations are cultured under conditions that support organoid growth. Brightfield and corresponding fluorescence images of the culturing wells are captured and analyzed using trained machine learning algorithms. These algorithms identify and distinguish cancer organoid cells from immune cells, characterizing the morphological changes caused by immune cell-based therapies. The outcome is an analytical report that includes a characterization of cancer organoid cell death caused by the therapy.

Career Highlights

Brandon Mapes is currently employed at Tempus AI, Inc., where he continues to contribute to advancements in cancer treatment. His work is pivotal in bridging the gap between technology and healthcare, particularly in the realm of personalized medicine.

Collaborations

One of his notable collaborators is Chi-Sing Ho, with whom he works closely to further their research initiatives.

Conclusion

Brandon Mapes exemplifies the spirit of innovation in the medical field, particularly in cancer research. His contributions through his patent and work at Tempus AI, Inc. are paving the way for more effective cancer therapies.